- Home
- ATAI vs DCO Comparison
ATAI vs DCO Comparison
Compare ATAI & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATAI | DCO |
|---|---|---|
| Founded | 2018 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATAI | DCO |
|---|---|---|
| Price | $3.98 | $120.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $13.86 | ★ $128.40 |
| AVG Volume (30 Days) | ★ 3.8M | 162.3K |
| Earning Date | 03-16-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,018,000.00 | ★ $806,224,000.00 |
| Revenue This Year | $956.49 | $6.12 |
| Revenue Next Year | N/A | $8.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 811.78 | 3.17 |
| 52 Week Low | $1.15 | $51.76 |
| 52 Week High | $6.75 | $124.12 |
Technical Indicators
Market Signals| Indicator | ATAI | DCO |
|---|---|---|
| Relative Strength Index (RSI) | 53.26 | 68.25 |
| Support Level | $3.32 | $118.94 |
| Resistance Level | $4.01 | $124.12 |
| Average True Range (ATR) | 0.24 | 4.09 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 75.89 | 75.47 |
Price Performance
Historical ComparisonAbout ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
About DCO Ducommun Incorporated
Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.